Medical Pharmacology: Antiarrhythmic Drugs
Practice Questions
Click on the correct answer.
Nondihydropyridine calcium channel antagonists specifically antagonize calcium-dependent slow action potentials in both the sinoatrial and AV nodes.
- True
- False
Example(s) of nondihydropyridine calcium channel blocker(s):
- Diltiazem
- Verapamil
- Both
- Neither
Pharmacological and electrophysiological effect(s) of diltiazem may include(s):
- Lengthening of the AV nodal refractory period.
- Peripheral vasoconstriction
- Both
- Neither
Which one(s) of the following pharmacokinetic/dosing characteristics of diltiazem and verapamil is/are correct?
- Oral administration is associated with bioavailability on the order of 40%.
- Both drugs are susceptible to first pass hepatic metabolism.
- The principal route of elimination is renal.
- A only
- B & C
- A & B
- A, B & C
Therapeutic applications of diltiazem and verapamil include which one(s) of the following?
- Termination of supraventricular tachycardia
- Prevention of supraventricular tachycardia recurrence
- Management of ventricular rate in the presence of atrial fibrillation/flutter.
- A & B
- A, B & C
Diltiazem administration may prevent ventricular fibrillation secondary to coronary artery vasospasm.
- True
- False
Verapamil and diltiazem (IV administration) is effective in management of Wolff-Parkinson-White syndrome when complicated by atrial fibrillation.
- True
- False
Verapamil must be administered with caution in those patients exhibiting impaired renal perfusion with renal dysfunction.
- True
- False
If you wish to return to the Table of Contents
in ENGLISH, press the RETURN button above. |
Otherwise, if the text is NOT displayed in
English and you are ready to leave this page,
Press here
to return to the Table of Contents
|